product and the level of HepG2 total RNA spiked. The assay is sensitive down to a detection level of one HepG2 cell. Alb mRNA was detected in 50% of 18 normal subjects and afp mRNA in only two normal subjects. The alb mRNA cut-off level for the normal was exceeded by seven normal subjects and 34 out of 64 HCC patients, and that for afp mRNA was exceeded by six HCC patients but none of the normal subjects. The level of alb mRNA detected was not linearly proportional to the amount of afp mRNA detected in peripheral blood of the same patients, suggesting heterogeneous expression of alb and afp genes in different circulating tumour cells. In addition, no significant linear association between the levels of afp mRNA and serum AFP was observed. Semiquantification of both mRNA markers for HCC cell detection may prove useful in prediction of metastases.
The only hope of long-term survival for patients with hepatocellular carcinoma (HCC) is surgical resection or liver transplantation. However, these options are frequently limited by the presence of intrahepatic and/or extrahepatic metastases. Recurrence of micrometastases may develop following surgical intervention, which is reported in a number of tumour types to produce tumour cell shedding. Detection of metastasis at an early stage might permit a more appropriate choice of patients for surgery and could be valuable in monitoring their response to chemotherapy, radiotherapy, resection or transplantation.
Recently, it has been proposed that it is possible to infer the presence of circulating HCC cells, and hence the potential for metastasis formation, if mRNAs of hepatocyte-specific albumin (alb) and a-fetoprotein (afp) genes are detected in peripheral blood by reverse transcriptase polymerase chain reaction (RT-PCR). Indeed, there is evidence that detection of alb mRNA and afp mRNA is strongly associated with the presence of metastases (Hillaire et al, 1994; Matsumura et al, 1994; Kar and Carr, 1995; Komeda et al, 1995; Nambu et al, 1995) . An analogous approach has been applied in patients with breast cancer, neuroblastoma, melanoma and colon cancer using mRNAs of cytokeratin 19, tyrosine hydroxylase, tyrosinase and carcinoembryonic antigen as markers respectively (Naito et al, 1991; Burchill et al, 1994; Datta et al, 1994; Gerhard et al, 1994) . On the basis of such studies, it appears that the RT-PCR assay is sufficiently sensitive to detect 1-100 tissue-specific cells among 106 peripheral blood mononuclear cells (PMNCs) .
Nevertheless, the specificity of the RT-PCR test has been brought into question as alb mRNA was detected in peripheral blood of many normal subjects and afp mRNA was identified in peripheral blood of patients with chronic hepatitis or cirrhosis (Matsumura et al, 1994; Nambu et al, 1995) . This phenomenon, attributed to 'illegitimate transcription', was also noticed when mRNAs of P-glycoprotein (P-Gp) 9.5, tyrosinase, cytokeratin 18 and 19, and epithelial membrane antigen were used as markers for other tumours (Mattano et al, 1992; Naito et al, 1991; Burchill et al, 1994 Burchill et al, , 1995 . In this study, we have attempted to develop a semiquantitative estimation of the amounts of 'hepatocyte-specific' mRNAs in the circulation of normal subjects and HCC patients for differential detection of HCC cells rather than normal PMNCs. Also, the mass of circulating HCC cells in HCC patients was estimated with reference to the number of hepatoblastoma cells (HepG2). In addition, the correlation between the levels of alb mRNA and afp mRNA in the same patients was studied, as was the association between the amounts of a,fp mRNA and serum AFP.
MATERIALS AND METHODS
Whole blood samples from 18 normal subjects and 64 HCC patients were collected. The HCC patients all had either histological confirmation of the diagnosis or the combination of a hepatic -CCT GM TTG CTA TGT GTC TGG GTT TCA TCC A-3'   P2-Microglobulin 2 5'-GGA GCA ACC TGC TCA GAT ACA TCA MC ATG G-3'   Albumin 1  5'-TGC TTG MT GTG CTG ATG ACA GGG 3'  Albumin 2 5'-MG GCA AGT CAG CAG GCA TCT CAT C-3' Albumin P 5'-CAC AGC ATT CCT TCA GTT TAC TGG AGA TCG-3' a-Fetoprotein 1 5'-TGC AGC CM AGT GM GAG GGA AGA-3' a-Fetoprotein 2 5'-CAT AGC GAG CAG CCC MA GM GM-3' a-Fetoprotein P 5'-CAG CAT CGA TCC CAC TH TCC MG TTC CAG-3' mass detected by an imaging procedure and a raised serum AFP level in a setting of chronic liver disease.
Peripheral mononuclear cell isolation and RNA extraction Peripheral mononuclear cells (PMNCs) were isolated from 20 ml of citrated blood collected from normal subjects or HCC patients using Ficoll-Paque plus (Pharmacia). The cells were washed with 30 ml of phosphate-buffered saline (PBS). After centrifugation at 100 g for 10 min, the cell pellet was resuspended in 1 ml of PBS and the PMNC number was counted in a haemocytometer. After centrifugation, the cell pellet was resuspended in 0.5 ml of guanidinium thiocyanate solution (4 M guanidinium thiocyanate, 0.5% Sarkosyl, 25 mm sodium citrate (pH 7) and 0.1 M 2-mercaptoethanol) and frozen at -70°C for temporary storage. Total RNA was extracted by a single-step method (Chomczynski and Sacchi, 1987) .
Cell culture
The hepatoblastoma cell line HepG2 (Aden et al, 1979; Knowles et al, 1980) was used to establish a calibration assay for assessment of the amounts of mRNA markers. The cell line was cultivated in RPMI medium (Gibco, BRL) to which was added Hepes, glutamine, penicillin and streptomycin, and supplemented with 10% fetal bovine serum (Gibco, BRL). The medium was changed every 3 days and the cells were harvested when the growth was subconfluent. The total cell number was counted in a haemocytometer. RT-PCR and semiquantitative Southern blot analysis Total RNA (0.5 or 1 jig) was denatured at 65°C for 2 min and annealed with 1 jig of random primers at 37'C for 10 min. The gene specificities of the PCR products were verified by non-radioactive Southern blot analysis using digoxigenin-3'-end labelled gene-specific oligonucleotides (albumin P or afetoprotein P, Table 1 ) followed by chemiluminescent detection with CSPD (disodium 3-(4-methocyspiro{ 1,2-dioxetane-3,2"-(5"-chloro) tricyclo[3.3.1.137] decan}-4-yl) phenyl phosphate (Boehringer Mannheim). The volumes of the bands were analysed and quantified by imaging densitometry (model GS-700, BioRad).
RESULTS

Linear calibration curves for semiquantification
In the spiking experiment, the band volumes of alb and afp PCR products increased with the amount of HepG2 total RNA spiked into total RNA of normal PMNCs. The relationship between the amount of alb PCR product and the level of HepG2 total RNA spiked was found to be linear on logarithmic scales, in a 106 fold range of 1.65-1 650 000 pg total RNA (or 1-106 HepG2 cells) ( Figure 1 ) and that between the amount of affi PCR product and the level of HepG2 total RNA was linear in a 106-fold range of 165-1 650 000 pg total RNA Albumin mRNA in normal subjects and HCC patients An alb mRNA signal was detected in peripheral blood of 9 out of 18 (50%) normal subjects and 44 out of 64 (69%) HCC patients. The alb mRNA level that permitted the best discrimination between the normal and HCC subjects was determined to be 1 pg of HepG2 total RNA, which is below the limit of detection. This value, arbitrarily deemed the 'optimal cut-off' of the normal reference range, was exceeded in seven normal subjects and 34 HCC patients (Figure 3 ). The mean alb mRNA level among the normal group (n = 18) was equivalent to 0.51 ng of HepG2 total RNA per 20 ml of peripheral blood with a corresponding mean level of 3778.19 ng in the HCC group (n = 64) (P < 0.05, Mann-Whitney U-Wilcoxon rank sum W-test). Figure 3 Alb mRNA levels equivalent to HepG2 total RNA (pg) (on logarithmic scales) in peripheral blood (20 ml) from normal subjects (A) and HCC patients (U). The levels were calculated according to the calibration curve of the volume of the alb PCR product against HepG2 total RNA on logarithmic scales. The optimal alb mRNA cut-off point and the upper limit of the reference range for the normal group are indcated Alpha-fetoprotein mRNA in normal subjects and HCC patients
In contrast, there was almost no overlap in the afp mRNA levels between the normal and HCC groups. An afp mRNA signal was detected in only 2 out of 18 normal subjects compared with 13 out of 64 HCC patients. The level of afp mRNA that permitted the best discrimination between the normal and HCC subjects was determined to be 10 pg of HepG2 total RNA, which is below the limit of detection. This value, arbitrarily deemed the 'upper limit' of the normal reference range, was exceeded in six HCC patients but none of the normal subjects (Figure 4) (Figures 5 and 6 ) and who developed lung metastasis 2 months after the RT-PCR diagnosis.
Association between albumin mRNA, alpha-fetoprotein mRNA and serum AFP
In this investigation, the amount of alb mRNA detected was not linearly proportional to the level of afp mRNA detected (on logarithmic scales) in peripheral blood of the 36 HCC patients who were positive for alb mRNA and/or afp mRNA (r = -0.27, P < 0.06, Pearson correlation). In addition, there was no significant association between the levels of aft mRNA and serum AFP (on logarithmic scales) among the 13 HCC patients tested positive for aft mRNA (r = -0.13, P < 0.34, Pearson correlation; Table 3 ).
DISCUSSION
Our semiquantitative RT-PCR technique is a sensitive assay that confirms the gene specificities of the PCR products, and can detect a single HepG2 cell among 106 PMNCs. This technique is of similar sensitivity to the nested RT-PCR method, as, described previously (Matsumura et al, 1995) . It has been reasoned that, as the alb gene is specifically transcribed in liver cells, any albexpressing cells detected in peripheral blood should be abnormal and, presumably, are HCC cells (Hillaire et al, 1994; Kar and Carr, 1995) . Kar and Carr (1995) reported that alb mRNA was not detected in peripheal blood of six normal subjects by RT-PCR. However, Matsumura et al (1995) demonstrated the presence of alb mRNA in all 26 normal subjects by a more sensitive nested RT-PCR assay. In this investigation, intermediate results were shown with positive signals of alb mRNA detected in 9 out of 18 (50%) normal subjects. This clearly suggests that the frequency of alb mRNA detection depends on the sensitivity of the assay used and the quantitative assays need to be optimized for discrimination between normal and malignant cells. We cannot rule out the possibility that alb mRNA detected in peripheral blood of the normal subjects is derived from normal circulating hepatocytes. However, it is more reasonable to consider this as illegitimate transcription of alb gene at different levels in PMNCs (Chelly et al, 1989) . In fact, alb mRNA has been detected in organs such as testis, uterus, placenta and yolk sac as well as the liver in rats (McLeod et al, 1989) . To determine the extent to which the levels of alb mRNA indicate any subsequent metastases, the clinical outcomes of the high-risk HCC patients with significantly high alb mRNA levels detected are being followed up closely. It is noteworthy that there is an overlap in alb mRNA levels between normal and HCC subjects. The alb optimal cut-off level was exceeded in seven normal subjects and 34 HCC patients. Among the 34 HCC patients, 11 patients had alb mRNA levels higher than the upper limit of the normal reference range. Three of these 11 patients demonstrated alb mRNA levels more than 1000-fold higher than the upper limit. These grossly raised alb mRNA levels presumably represent genuine detection of circulating HCC cells. The mass of circulating malignant HCC cells was estimated only with reference to HepG2 cells, which serve, in turn, as a reference for comparison between the normal and HCC subjects. Clearly, the presence of alb mRNA in peripheral blood does not always indicate circulating HCC cells, as it is readily detected in some normal subjects. This emphasizes the importance of developing a semiquantitative RT-PCR assay for differentiation between normal and HCC subjects. Further, the lack of any direct correlation between the levels of alb-and aft, mRNA implies that there could be considerable heterogeneity in the expression of alb and aftu genes among different HCC cells. We suspect that, as the aftp gene is only very weakly expressed in normal adult hepatocytes (Tamaoki and Fausto, 1984) , the level of afp mRNA detected in peripheral blood of HCC patients may provide a closer approximation to the true number of malignant HCC cells than does the amount of alb mRNA. To improve our semiquantificative analysis, we are currently applying patients' tumour and normal liver tissues to set up 'patient-specific' calibration curves for quantitation.
It is unlikely that alb mRNA and aft mRNA detected in peripheral blood by RT-PCR are derived from lysed hepatocytes (Kar and Carr, 1995; Komeda et al, 1995) as free mRNAs from cytolysis are readily degraded by RNAases in the circulation. Some atypical cells with large nuclei were noticed in the smeared peripheral blood of a patient who was tested positive for afp mRNA (Komeda et al, 1995) . Although these cells may represent putative circulating HCC cells, their potential for leading to development of metastases is still unknown. It is well established that only a small percentage of circulating HCC cells with malignant potential can survive in the circulation and ultimately cause metastasis, and a certain minimal tumour cell burden appears to be essential for metastasis formation (Liotta et al, 1974) . Therefore, semiquantification of circulating HCC cells may be potentially useful for prediction of the development of metastasis.
It is well documented that the level of aft transcription and the amounts of AFP synthesis and secretion may vary among HCC cells in liver tumours of different HCC patients (Di Bisceglie et al, 1986) . This is in agreement with the observation that HCC patients exhibit a wide range of serum AFP levels. Generally, the levels of aft mRNA in HCC sections of liver tumour tissue parallel the amount of serum AFP in the patient (Belanger et al, 1983; Otsuru C Cancer Research Campaign 1997 Semiquantification of circulating HCC cells 633 et al, 1988) . However, strong afp mRNA signals have been detected even in tumours obtained from patients with low serum AFP levels (Di Bisceglie et al, 1986) . Nambu et al (1995) have demonstrated, in their preliminary studies, an afp mRNA signal in peripheral blood of HCC patients with serum AFP levels of < 20 ng ml-' but no such signal in HCC patients with serum AFP levels of > 400 ng ml-'. In the present study, the intensity of the afp mRNA signal detected in peripheral blood was not linearly proportional to the level of serum AFP. For instance, a very high level of afp mRNA was shown in patient P57 with a serum AFP level of < 10 ng ml-', whereas only minimal levels of afp mRNA were detected in patients P30, P44 and P51 with very high serum AFP levels (Table 3) . Thus, it appears that serum AFP levels are unrelated to the risk of metastasis, whereas ak mRNA detected in peripheral blood may be a more reliable marker for quantitation of circulating HCC cells and prediction of metastasis formation.
